Literature DB >> 2905509

In vitro lecithinase activity and sensitivity to 22 antimicrobial agents of Clostridium perfringens isolated from necrotic enteritis of broiler chickens.

F Kondo1.   

Abstract

Viable Clostridium perfringens ranging from 10(5) to 10(8) g-1 was detected in all of 88 intestinal content specimens of necrotic enteritis in broiler chickens. In vitro lecithinase activity and sensitivity to 22 antimicrobial agents were determined for the 88 isolates. The activities of lecithinase in the culture filtrate of isolates were estimated to be 0.5 to 4.0 AE ml-1 as alpha-antitoxin equivalent. With reference to antimicrobial activity penicillins and cephazolin showed excellent activity and no resistance; peptides, of the agents used as growth promoters, showed that all except bacitracin had low minimum inhibitory concentration levels (1.6 micrograms ml-1 or less) against this organism; polyethers of monensin, salinomycin and lasalocid were generally adequate in low concentrations while there was a high level of resistance to three tetracyclines in 90 per cent of the strains and all isolates were insusceptible to streptomycin of the aminoglycoside antibiotics.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2905509

Source DB:  PubMed          Journal:  Res Vet Sci        ISSN: 0034-5288            Impact factor:   2.534


  10 in total

1.  Comparison between a live, attenuated anticoccidial vaccine and an anticoccidial ionophore, on performance of broilers raised with or without a growth promoter, in an initially Eimeria-free environment.

Authors:  L Waldenstedt; A Lundén; K Elwinger; P Thebo; A Uggla
Journal:  Acta Vet Scand       Date:  1999       Impact factor: 1.695

Review 2.  Clostridial enteric diseases of domestic animals.

Authors:  J G Songer
Journal:  Clin Microbiol Rev       Date:  1996-04       Impact factor: 26.132

Review 3.  Antimicrobial growth promoters used in animal feed: effects of less well known antibiotics on gram-positive bacteria.

Authors:  Patrick Butaye; Luc A Devriese; Freddy Haesebrouck
Journal:  Clin Microbiol Rev       Date:  2003-04       Impact factor: 26.132

4.  Effect of antibiotic growth promoters and anticoccidials on growth of Clostridium perfringens in the caeca and on performance of broiler chickens.

Authors:  K Elwinger; E Berndtson; B Engström; O Fossum; L Waldenstedt
Journal:  Acta Vet Scand       Date:  1998       Impact factor: 1.695

5.  Factors affecting the incidence of necrotic enteritis, caecal carriage of Clostridium perfringens and bird performance in broiler chicks.

Authors:  K Elwinger; C Schneitz; E Berndtson; O Fossum; B Teglöf; B Engstöm
Journal:  Acta Vet Scand       Date:  1992       Impact factor: 1.695

6.  Dietary Non-Drug Feed Additive as an Alternative for Antibiotic Growth Promoters for Broilers During a Necrotic Enteritis Challenge.

Authors:  Ali Calik; Islam I Omara; Mallory B White; Nicholas P Evans; T Peter Karnezos; Rami A Dalloul
Journal:  Microorganisms       Date:  2019-08-13

7.  Protective Effects of Lactobacillus plantarum Lac16 on Clostridium perfringens Infection-Associated Injury in IPEC-J2 Cells.

Authors:  Yuanhao Zhou; Baikui Wang; Qi Wang; Li Tang; Peng Zou; Zihan Zeng; Huihua Zhang; Li Gong; Weifen Li
Journal:  Int J Mol Sci       Date:  2021-11-17       Impact factor: 5.923

Review 8.  The successful experimental induction of necrotic enteritis in chickens by Clostridium perfringens: a critical review.

Authors:  Bahram Shojadoost; Andrew R Vince; John F Prescott
Journal:  Vet Res       Date:  2012-10-26       Impact factor: 3.683

9.  The role of supplemental glycine in establishing a subclinical necrotic enteritis challenge model in broiler chickens.

Authors:  Guang-Da Xue; Shu-Biao Wu; Mingan Choct; Robert A Swick
Journal:  Anim Nutr       Date:  2017-05-25

Review 10.  Centennial Review: Factors affecting the chicken gastrointestinal microbial composition and their association with gut health and productive performance.

Authors:  Yugal Raj Bindari; Priscilla F Gerber
Journal:  Poult Sci       Date:  2021-11-21       Impact factor: 3.352

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.